Dean Witter Reynolds Inc. v. Byrd

DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth

Retrieved on: 
Thursday, October 19, 2023

SAN DIEGO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- DMK Pharmaceuticals Corporation (NASDAQ: DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders, today announced a series of management changes to optimize its leadership structure. Seth Cohen has been appointed as Chief Financial Officer and John Dorbin will assume the position of General Counsel Corporate Secretary. Mr. Cohen will be succeeding the outgoing interim CFO and President and Chief Operating Officer, David Marguglio. These organizational changes will be effective immediately. The new team is tasked with operating a lean and effective organization committed to increasing the sales of DMK’s existing commercial products and advancing its clinical pipeline.

Key Points: 
  • Seth Cohen has been appointed as Chief Financial Officer and John Dorbin will assume the position of General Counsel Corporate Secretary.
  • Mr. Cohen will be succeeding the outgoing interim CFO and President and Chief Operating Officer, David Marguglio.
  • The new team is tasked with operating a lean and effective organization committed to increasing the sales of DMK’s existing commercial products and advancing its clinical pipeline.
  • “We welcome Seth and John to our executive leadership team at a critical point for our company,” said Eboo Versi, M.D., Ph.D., CEO of DMK Pharmaceuticals.

AARON'S NAMES TWO NEW INDEPENDENT BOARD MEMBERS

Retrieved on: 
Wednesday, September 13, 2023

"On behalf of the entire Board of Directors, I would like to welcome Wali and Kris as the newest members of the Aaron's board," said John Robinson, chair of The Aaron's Company Board of Directors.

Key Points: 
  • "On behalf of the entire Board of Directors, I would like to welcome Wali and Kris as the newest members of the Aaron's board," said John Robinson, chair of The Aaron's Company Board of Directors.
  • He also currently serves as a Venture Partner for Delta-v Capital, a technology-focused growth capital investment firm.
  • In addition, he is the principal investor and co-founder of Millie's Homemade Ice Cream and Southern Steer Franchising.
  • He is currently a Trustee of Washington and Lee University and also serves as a board member of several non-profit and charitable organizations.